News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
829,400 Results
Type
Article (85551)
Company Profile (700)
Press Release (743149)
Section
Business (231998)
Career Advice (4103)
Deals (39641)
Drug Delivery (115)
Drug Development (90603)
Employer Resources (194)
FDA (17936)
Job Trends (17269)
News (395169)
Policy (39614)
Tag
Academia (2972)
Alliances (56406)
Alzheimer's disease (1318)
Approvals (17868)
Artificial intelligence (132)
Bankruptcy (394)
Best Places to Work (12463)
Biotechnology (480)
Breast cancer (117)
Cancer (1064)
Career advice (3511)
Cell therapy (257)
Clinical research (71382)
Collaboration (380)
Compensation (182)
COVID-19 (2794)
C-suite (92)
Data (1042)
Diabetes (137)
Diagnostics (6600)
Drug pricing (100)
Earnings (94300)
Employer resources (166)
Events (126289)
Executive appointments (282)
FDA (18396)
Funding (315)
Gene therapy (186)
GLP-1 (675)
Government (5042)
Healthcare (20642)
Infectious disease (2872)
Inflammatory bowel disease (120)
Interviews (807)
IPO (17554)
Job creations (5178)
Job search strategy (2854)
Layoffs (486)
Legal (10032)
Lung cancer (169)
Manufacturing (190)
Medical device (14256)
Medtech (14261)
Mergers & acquisitions (22056)
Metabolic disorders (424)
Neuroscience (1605)
NextGen Class of 2024 (7645)
Non-profit (5049)
Northern California (1362)
Obesity (248)
Opinion (244)
Patents (103)
People (64053)
Pharmaceutical (141)
Phase I (21985)
Phase II (31014)
Phase III (23376)
Pipeline (435)
Postmarket research (3534)
Preclinical (9937)
Radiopharmaceuticals (249)
Rare diseases (222)
Real estate (7370)
Regulatory (25877)
Research institute (2638)
Resumes & cover letters (648)
Southern California (1219)
Startups (4271)
United States (12960)
Vaccines (626)
Weight loss (211)
Date
Today (108)
Last 7 days (764)
Last 30 days (3405)
Last 365 days (36293)
2024 (33068)
2023 (42566)
2022 (53928)
2021 (58726)
2020 (57671)
2019 (51341)
2018 (39125)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1262)
Arizona (213)
Asia (49252)
Australia (8687)
California (3147)
Canada (1193)
China (237)
Colorado (110)
Connecticut (135)
Europe (112768)
Florida (387)
Georgia (91)
Illinois (364)
Indiana (194)
Kansas (103)
Maryland (596)
Massachusetts (2602)
Michigan (140)
Minnesota (252)
New Jersey (937)
New York (890)
North Carolina (804)
Northern California (1362)
Ohio (124)
Pennsylvania (769)
South America (1646)
Southern California (1219)
Texas (413)
Washington State (363)
829,400 Results for "tetra bio pharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Pharm Country
Acasti Pharma to Attend BIO International Convention 2024
Acasti Pharma Inc. announced that the Company will be participating in the BIO International Convention taking place at the San Diego Convention Center from June 3-6, 2024.
May 28, 2024
·
6 min read
BioCapital
IGC Pharma to Attend BIO International Convention 2024
IGC Pharma, Inc, announced that the Company will be participating in the BIO International Convention taking place at the San Diego Convention Center from June 3-6, 2024.
May 21, 2024
·
3 min read
Business
Pharma-Bio Serv Announces Results for the Quarter Ended April 30, 2024
Pharma-Bio Serv, Inc. announced that revenues for the three and six months ended April 30, 2024 were approximately $2.4 and $4.8, million, respectively, a decrease of approximately $2.2 and $4.0 million when compared to the same periods last year.
June 14, 2024
·
2 min read
Tetra Bio-Pharma Announces Listing to OTCPink Market
Tetra Bio-Pharma Inc. announced that its common shares began trading on the OTC Markets Group’s OTCPink Market in the United States under the symbol “TBPMF” effective at the opening of trading on Friday, February 10, 2023 and will continue to trade on the Toronto Stock Exchange under the ticker symbol “TBP”.
February 10, 2023
·
4 min read
Editorial
Pharma’s Q3 Was a Rollercoaster Ride. Let’s Do It Again Next Quarter
Big Pharma had plenty of drama to keep journalists busy this quarter, which painted an accurate portrait of the wild and wonderful world of biopharma.
November 15, 2024
·
3 min read
·
Annalee Armstrong
Tetra Bio-Pharma Provides Update on Patent Applications for Novel Therapeutic ARDS-003
Tetra Bio-Pharma Inc. today announced the filing of three patent applications for its novel therapeutic, ARDS-003.
November 29, 2022
·
5 min read
Biotech Beach
GRI Bio to Present at the MedInvest Biotech & Pharma Investor Conference
GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”) today announced that Marc Hertz, PhD, Chief Executive Officer of GRI Bio, will present at the MedInvest Biotech & Pharma Investor Conference being held in New York City, NY on Wednesday, April 3, 2024 at 10:10 AM ET.
March 28, 2024
·
1 min read
Tetra Bio-Pharma Provides Update on Its REDUVO New Drug Submission
Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX: TBP) (OTCQB: TBPMF) (FRA:JAM1) a leader in cannabinoid-derived drug discovery and development is providing its shareholders with a regulatory status update on the REDUVO™ New Drug Submission (NDS).
November 18, 2022
·
4 min read
Pharma-Bio Serv Announces Results for the Quarter Ended January 31, 2024
Pharma-Bio Serv, Inc. (“Pharma-Bio Serv” or the “Company”) (OTCQB:PBSV) today announced that revenues for the quarter ended January 31, 2024 were approximately $2.4 million, a decrease of approximately $1.9 million when compared to the same period last year.
March 18, 2024
·
2 min read
Mergers & acquisitions
Broken Deals: 4 Pharma Assets Returned to Biotech This Year
Not all licensing deals are successful. Here,
BioSpace
examines a few noteworthy assets that Big Pharma returned in the last 12 months.
August 27, 2024
·
5 min read
·
Mollie Barnes
1 of 82,940
Next
